Clinical Trial Update: Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of two dosages of the herbal product BNO 1016 for chronic rhinosinusitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• BNO 1016

Snippet

Sponsor: Bionorica SE | Conditions: Chronic Sinusitis | Phase 3 | Status: COMPLETED